ClinicalTrials.gg
RecruitingNCT05199025BIGPROMISEUpdated Apr 27, 2026

Biomarkers in Perioperative Management

An observational study in Postoperative Complications, Quality of Life and Death, sponsored by St. Antonius Hospital. Recruiting at 2 sites in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by St. Antonius Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Oct 2021; still recruiting 5 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Study summary

Rationale: The rate of postoperative complications after high-risk surgery remains high despite recent advances in perioperative management. There is a lack of objective and reliable information that can be used for risk stratification and to guide treatment decisions.

Objective: To describe the perioperative biomarker response in surgical patients with and without a postoperative complication and construct a preoperative and postoperative prediction model for postoperative complications. To systematically collect perioperative blood samples and clinical data in high-risk surgical patients for the development en analysis of biomarkers.

Study design: Multicenter, prospective, observational study. Study population: 4819 patients undergoing elective cardiac, colorectal, vascular and lung surgery.

Intervention (if applicable): Not applicable. Main study parameters/endpoints: Main study parameters are levels of PCT, CRPhs, IL-6, GDF-15, sFLT, NT-proBNP, cTNThs, CysC and NGAL. Main study endpoint is the occurrence of a major postoperative complication which is defined as a surgical site infection, pneumonia, sepsis, acute kidney injury, major adverse cardiovascular events or death within 30 days of surgery.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In each patient five blood samples will be drawn for analysis. Most of the blood samples are drawn simultaneously with routine perioperative laboratory testing, which is common in this study population. In case a patient is admitted to the Intensive Care Unit blood samples will be collected using an arterial line. There are no direct risks or benefits for patients included in the study.

02

Conditions studied

  • Postoperative Complications
  • Quality of Life
  • Death
03

In context

Postoperative Complications

1,332 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 251 across 537 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

St. Antonius Hospital is the lead sponsor of 97 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of patients undergoing surgery in the St. Antonius Hospital and the Amphia hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cardiac surgery (isolated coronary artery bypass grafting or combined with single valve surgery, isolated single valve surgery)
  • Gastrointestinal surgery (colorectal, pancreatic, gastric surgery).
  • Vascular surgery (open and endovascular aortic surgery, peripheral vascular surgery)
  • Lung surgery (pneumonectomy,(bi)(sleeve)lobectomy or segmentectomy)

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years
  • Pregnancy
  • Emergent surgery
  • No
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Interventions

  • Diagnostic testBiomarker

    Perioperative biomarker analyses

06

What researchers measure

Primary outcomes

  1. Postoperative complication

    a surgical site infection, pneumonia, sepsis, acute kidney injury, major adverse cardiovascular events or death

    Time frame: 30 days

Secondary outcomes

  1. Failure to rescue

    In-hospital death following a major complication

    Time frame: 30 days

  2. Mortality

    Death

    Time frame: 120 days

  3. DAH120

    Days alive and out of hospital

    Time frame: 120 days

  4. Disability

    Change in disability according to WHODAS 2.0 - 12 item

    Time frame: 120 days

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Reniers T, Noordzij P, Harding E, Ruven H, Thio M, Langelaan M, Dijkstra I, Vernooij L, Cremer O, Rettig TCD. Procalcitonin and interleukin-6 to diagnose infection in cardiac surgery patients with hyperinflammation: a two-centre, prospective cross-sectional study. BJA Open. 2026 Feb 19;17:100538. doi: 10.1016/j.bjao.2026.100538. eCollection 2026 Mar. PubMed 41768076 ↗
  • Noordzij PG, Ruven HJ, Reniers T, Idema RN, Thio MS, Cremer OL, Hollema N, Smit KN, Vernooij LM, Dijkstra IM, Rettig TC. Cohort profile of BIGPROMISE: a perioperative biobank of a high-risk surgical population. BMJ Open. 2024 Jun 11;14(6):e078307. doi: 10.1136/bmjopen-2023-078307. PubMed 38862228 ↗

Related links

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05199025
Lead sponsor
St. Antonius Hospital
Responsible party
dr. P. Noordzij (Principal Investigator, St. Antonius Hospital) — Principal investigator
First posted
Jan 20, 2022
Start date
Oct 12, 2021
Primary completion
Jun 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 27, 2026

Study contacts

Peter Noordzij
Contact
p.noordzij@antoniusziekenhuis.nl
0031883203000
Thijs Rettig
Contact
trettig@amphia.nl
0031883203000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion